The Nevada National Board Professional Learning Institute | Green | Activity http://www.nationalboardinstitute.com/members/violingum42/activity/ Activity feed for Green. Fri, 23 May 2025 17:06:54 -0700 https://buddypress.org/?v=9.1.1 en-US 30 hourly 2 23791ead944d97ed5fc35b8a17f0137a Green posted an update: Endometriosis is a relatively benign disease characterized […] http://www.nationalboardinstitute.com/activity/p/42019/ Sat, 08 Feb 2025 11:53:34 -0800 Endometriosis is a relatively benign disease characterized by endometrial tumors and uterus stroma. Apoptosis suppression is one of the most important pathological processes of endometriosis. Recently, several studies reported that human Wharton’s jelly stem cells (hWJSCs) can inhibit growth and proliferation of various cancer cells through…[Read more]

]]> 0 380d6fe24f1b072696063f288241fe13 Green posted an update: und combined with the VI and VA can improve the diagnostic […] http://www.nationalboardinstitute.com/activity/p/38594/ Tue, 04 Feb 2025 12:00:54 -0800 und combined with the VI and VA can improve the diagnostic specificity, accuracy and PPV without reducing the diagnostic sensitivity.

A VI value 4.05 is a cut-off value with good diagnostic efficacy. The residual root-like and crab claw-like VAs are the characteristic VAs of malignant lesions. Conventional ultrasound combined with the VI and VA…[Read more]

]]> 0 400983d82677fac708f6e9ca23c3a5dd Green posted an update: 001), vena contracta -0.11 cm (95% CI -0.20 to -0.02; P […] http://www.nationalboardinstitute.com/activity/p/37718/ Mon, 03 Feb 2025 11:56:58 -0800 001), vena contracta -0.11 cm (95% CI -0.20 to -0.02; P< 0.05), and effective regurgitant orifice area -0.03 cm

(95% CI -0.06 to -0.01; P< 0.05). There were non-significant improvements in LV ejection fraction and volumes. Survival over 1year was 89% with no difference between mild (96%) and moderate (86%) SMR (log-rank P= 0.22). Progressi…[Read more]

]]> 0 8d3e7285ba8af93f57b9c03aea432271 Green posted an update: Using the tumor growth rate, 90% of all patients showed a […] http://www.nationalboardinstitute.com/activity/p/31707/ Tue, 28 Jan 2025 17:18:27 -0800 Using the tumor growth rate, 90% of all patients showed a tumor reduction between first and final response evaluation. The 6-month, 1-, 2- and 3-year overall survival rates were 86.5%, 67.4%, 47.2%, and 33.7%, with a median survival of 45, 24, 15, and 14 months for complete response, partial response, stable disease, and progressive disease,…[Read more]

]]> 0 574e59130f54d14ae30b23ba79006bb9 Green became a registered member http://www.nationalboardinstitute.com/activity/p/31652/ Tue, 28 Jan 2025 17:14:24 -0800 0